alpha-KDN-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Term ID

CHEBI:71442

Synonyms

(6R)-3-deoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)2-acetamido-2-deoxy-beta-D-glucopyranose
3-deoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonyl-(2->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
alpha-KDN-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
deamino-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine
KDNa2-3Galb1-4GlcNAcb
KDNalpha2-3Galbeta1-4GlcNAcbeta
O-3-deoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->3)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose

Definition

A linear amino trisaccharide consisting of alpha-KDN, beta-D-galactose and N-acetyl-beta-D-glucosamine residues linked sequentially (2->3) and (1->4).

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: amino trisaccharide glucosamine oligosaccharide

amino trisaccharide glucosamine oligosaccharide Show first 5 Terms
has_role: epitope

epitope Show first 5 Terms

Phenotype

Phenotype resulting from alpha-KDN-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype where environments contain alpha-KDN-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype modified by environments containing alpha-KDN-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Human Disease Model